Literature DB >> 16585408

Rho kinase polymorphism influences blood pressure and systemic vascular resistance in human twins: role of heredity.

Tammy M Seasholtz1, Jennifer Wessel, Fangwen Rao, Brinda K Rana, Srikrishna Khandrika, Brian P Kennedy, Elizabeth O Lillie, Michael G Ziegler, Douglas W Smith, Nicholas J Schork, Joan Heller Brown, Daniel T O'Connor.   

Abstract

The Rho/Rho kinase (ROCK) pathway is implicated in experimental hypertension. We, therefore, explored the role of ROCK2 genetic variation in human blood pressure (BP) regulation, exploiting the advantages of a human twin sample to probe heritability. The focus of this work is the common nonsynonymous variant at ROCK2: Thr431Asn. Cardiovascular and autonomic traits displayed substantial heritability (from approximately 33% to 71%; P<0.05). The Asn/Asn genotype (compared with Asn/Thr or Thr/Thr) was associated with greater resting systolic (P<0.001), diastolic (P<0.0001), and mean BP (P<0.0001); allelic variation at ROCK2 accounted for up to approximately 5% of BP variation (P<0.0001). Systemic vascular resistance was higher in Asn/Asn individuals (P=0.049), whereas cardiac output, large artery compliance, and vasoactive hormone secretion were not different. Coupling of the renin-angiotensin system to systemic resistance and BP was diminished in Asn/Asn homozygotes, suggesting genetic pleiotropy of Thr431Asn, confirmed by bivariate genetic analyses. The Asn/Asn genotype also predicted higher BP after environmental (cold) stress. The rise in heart rate after cold was less pronounced in Asn/Asn individuals, consistent with intact baroreceptor function, and baroreceptor slope was not influenced by genotype. Common genetic variation (Thr431Asn) at ROCK2 predicts increased BP, systemic vascular resistance (although not large artery compliance), and resistance in response to the endogenous renin-angiotensin system, indicating a resistance vessel-based effect on elevated BP. The results suggest that common variation in ROCK2 exerts systemic resistance-mediated changes in BP, documenting a novel mechanism for human circulatory control, and suggesting new possibilities for diagnostic profiling and treatment of subjects at risk of developing hypertension.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16585408     DOI: 10.1161/01.HYP.0000217364.45622.f0

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  40 in total

Review 1.  The role of Rho protein signaling in hypertension.

Authors:  Gervaise Loirand; Pierre Pacaud
Journal:  Nat Rev Cardiol       Date:  2010-08-31       Impact factor: 32.419

2.  Measurement of Rho-associated kinase (ROCK) activity in humans: validity of leukocyte p-MBS/t-MBS in comparison with vascular response to fasudil.

Authors:  Takaki Hata; Chikara Goto; Junko Soga; Takayuki Hidaka; Yuichi Fujii; Naomi Idei; Noritaka Fujimura; Tatsuya Maruhashi; Shinsuke Mikami; Yasuki Kihara; Kazuaki Chayama; Kensuke Noma; James K Liao; Yukihito Higashi
Journal:  Atherosclerosis       Date:  2010-10-12       Impact factor: 5.162

Review 3.  Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.

Authors:  Jianjian Shi; Lei Wei
Journal:  J Cardiovasc Pharmacol       Date:  2013-10       Impact factor: 3.105

4.  Common functional genetic variants in catecholamine storage vesicle protein promoter motifs interact to trigger systemic hypertension.

Authors:  Kuixing Zhang; Fangwen Rao; Lei Wang; Brinda K Rana; Sajalendu Ghosh; Manjula Mahata; Rany M Salem; Juan L Rodriguez-Flores; Maple M Fung; Jill Waalen; Bamidele Tayo; Laurent Taupenot; Sushil K Mahata; Daniel T O'Connor
Journal:  J Am Coll Cardiol       Date:  2010-04-06       Impact factor: 24.094

5.  Genome-wide strategies for discovering genetic influences on cognition and cognitive disorders: methodological considerations.

Authors:  Steven G Potkin; Jessica A Turner; Guia Guffanti; Anita Lakatos; Federica Torri; David B Keator; Fabio Macciardi
Journal:  Cogn Neuropsychiatry       Date:  2009       Impact factor: 1.871

Review 6.  Hereditary determinants of human hypertension: strategies in the setting of genetic complexity.

Authors:  Pei-an Betty Shih; Daniel T O'Connor
Journal:  Hypertension       Date:  2008-04-14       Impact factor: 10.190

7.  Two functional polymorphisms of ROCK2 enhance arterial stiffening through inhibiting its activity and expression.

Authors:  Yi-Chu Liao; Ping-Yen Liu; Hsiu-Fen Lin; Wen-Yi Lin; James K Liao; Suh-Hang H Juo
Journal:  J Mol Cell Cardiol       Date:  2014-12-03       Impact factor: 5.000

8.  Human dopamine beta-hydroxylase (DBH) regulatory polymorphism that influences enzymatic activity, autonomic function, and blood pressure.

Authors:  Yuqing Chen; Gen Wen; Fangwen Rao; Kuixing Zhang; Lei Wang; Juan L Rodriguez-Flores; Amber P Sanchez; Manjula Mahata; Laurent Taupenot; Ping Sun; Sushil K Mahata; Bamidele Tayo; Nicholas J Schork; Michael G Ziegler; Bruce A Hamilton; Daniel T O'Connor
Journal:  J Hypertens       Date:  2010-01       Impact factor: 4.844

9.  Y27632, a Rho-activated kinase inhibitor, normalizes dysregulation in alpha1-adrenergic receptor-induced contraction of Lyon hypertensive rat artery smooth muscle.

Authors:  Maria Regina Freitas; Masumi Eto; Jason A Kirkbride; Christa Schott; Jean Sassard; Jean-Claude Stoclet
Journal:  Fundam Clin Pharmacol       Date:  2009-03-09       Impact factor: 2.748

10.  The alpha2C-adrenoceptor deletion322-325 variant and cold-induced vasoconstriction.

Authors:  Eitan A Friedman; Paul A Harris; Alastair J J Wood; C Michael Stein; Daniel Kurnik
Journal:  Clin Auton Res       Date:  2009-05-15       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.